(MoneyNewsWire.Net, June 15, 2017 ) The Asia - Pacific Aptamers Market was worth $ 24 million in 2016 and estimated to reach $ 66 million by the end of 2021 with a growing potential of 22.50 %. Asia – Pacific aptamers market is predicted to have the highest CAGR over the forecast Period. Growth in the market will be driven by increasing use of aptamers for diagnostics, therapeutics and drug discovery.
Aptamers are oligonucleotides that bind to target protein, lipid, or nucleic acid molecules with a high specificity. Aptamers can be chosen from a pool of random-sequence oligonucleotides to bind a wide range of bio medically relevant proteins with specificities and affinities that are as good as antibodies. Aptamers are multipurpose and cost effective which offer alternative solutions to the antibodies. Aptamers exhibit important advantages relative to protein therapeutics in terms of synthetic accessibility, size and modification by medicinal chemistry.
Browse market data tables and in-depth TOC of the Asia - Pacific Aptamers Market to 2021 @ http://www.marketdataforecast.com/market-reports/asia-pacific-aptamers-market-1137/
The Major factors driving the growth of the Asia - Pacific market are advancement in technology, Growing R&D investments in pharmaceutical and biotechnology industries, low cost and high efficacy of aptamers in binding. Ethical issues for the aptamers that are obtained from animals, Stringent regulations in use of aptamers may hinder the growth of the market.
The Asia - Pacific Aptamers Market is broadly categorized by type into Peptide aptamers, Nucleic Acid aptamers. Nucleic Acid aptamers are further categorized into DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers.
Free sample of the report is available @ http://www.marketdataforecast.com/market-reports/asia-pacific-aptamers-market-1137/request-sample
Based on Application the market is categorized into Therapeutics Development, Diagnostics, Research and Development and on the basis of end users the market is segmented into Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres and on the basis of geography, the Asia - Pacific Aptamers market is analysed under various regions namely Japan, China, India and Australia.
Some of the key players operating in Asia - Pacific Aptamers region are AM Biotechnologies, Aptagen, Aptamer Sciences Inc., Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., SomaLogic Inc, TriLink BioTechnologies Inc., and Vivonics, Inc.
Avail discount @ http://www.marketdataforecast.com/market-reports/asia-pacific-aptamers-market-1137/request-discount
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Contact: Abhishek Shukla Sales Manager (International Business Development) Market Data Forecast Direct Line: +1-888-702-9626 Mobile: +91 998 555 0206 Mail: abhishek@marketdataforecast.com Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/ View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|